{
  "docId": "019de076-7875-700c-ad7b-09334d1affac",
  "docSlug": "269fd0192907b8870d0f7950fab9760e",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 20,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "overcrowded",
  "nDataPoints": 24,
  "notes": "The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-7875-700c-ad7b-09334d1affac/9",
  "deckHref": "/decks/019de076-7875-700c-ad7b-09334d1affac",
  "deckJsonHref": "/decks/019de076-7875-700c-ad7b-09334d1affac.json",
  "deckAnchorHref": "/decks/019de076-7875-700c-ad7b-09334d1affac#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.28,
        "x": 0.68,
        "y": 0.21
      },
      "kind": "chart",
      "text": "ROC Curves of Biomarker Prediction of IMV",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2a13c01c-89cf-4a5c-8a0e-c2974b07812a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.94,
        "x": 0.03,
        "y": 0.73
      },
      "kind": "paragraph",
      "text": "Bluejay clinical study assessed ability of Symphony IL-6 to predict risk for invasive mechanical ventilation (IMV) in COVID-19 patients at time of hospital admission. Favorable clinical performance demonstrated 89% sensitivity, 64% specificity and 98% NPV.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8e759cd4-3816-4f33-a7d8-fa955715f2aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.13,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Source: 1. Bluejay Diagnostics market research. 2. NPV = Negative Predictive Value. 3. Bluejay/Industry information, pending the location of the testing lab. 4. from FDA Emergency Use Authorization company filings",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b8a8006-1460-4dc6-b8a0-c3b92c6cfbd6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.6,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "table",
      "text": "Metric table comparing IL-6, CRP, and Lactate across AUC, Youden Index, Cutoff, Sensitivity, Specificity, and NPV.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "443dbfc3-11ba-42cb-a2bd-55eccf893fc8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.03,
        "y": 0.21
      },
      "kind": "title",
      "text": "IL-6 negative predictive value (NPV) superior to other standard biomarkers",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66830925-b0e3-4a57-8838-d3d5cfbb83ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.94,
        "x": 0.03,
        "y": 0.08
      },
      "kind": "title",
      "text": "Symphony™ IL-6 Potential Clinical Advantages v. Current Tests Used for Sepsis Patients",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38a02c9e-73fe-4086-a91a-6096318552de",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "e4185dea-766d-48c4-9cb1-93e216a431ec",
      "evidence": "Direct comparison of clinical metrics between three biomarkers.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 6,
      "beatId": "3e301610-2f38-402d-a7e9-46fe7d522b91",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 6-11 present the Symphony™ solution, highlighting its rapid, near-patient testing capabilities and potential clinical advantages.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 6,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "7cdcdecc-1740-435e-ad15-27053d16ea97",
      "evidence": "The solution slides present the benefits and advantages of Symphony™, aligning with the Golden Circle framework.",
      "position": 1,
      "objective": "Why is Symphony™ a better solution for sepsis diagnosis?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}